MedGenome
Business Services · Delaware, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
108 W 13th St, Wilmington, Delaware, 198...Phone Number
(888) 440-0954Website
www.medgenome.comRevenue
$84.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About MedGenome
MedGenome (www.medgenome.com) is a global leader in personalized medicine with 3 core businesses spanning genomic diagnostics, genomic research, and genomic medicine. MedGenome has a world class high-throughput Next-Generation Sequencing facility and bioinformatics team in Foster City, California, supporting biomarker identification, target discovery, and pre-clinical and clinical research programs for bio-pharma and academic institutions in the US, Europe and Canada. MedGenome is a market leader in genetic diagnostic testing in India and has created the largest known clinico-genomic datasets on South Asian populations. MedGenome has developed algorithms and tools to correlate genomic data with clinical and phenotypic information to provide deep insight into both rare and complex diseases at a genetic and molecular level to support drug development and personalized medicine programs.Explore more
MedGenome Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MedGenome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if MedGenome had a recent Job posting/layoffs
Earning: See what the market has to say on MedGenome recently announced quarterly report
Check out if MedGenome is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at MedGenome
Funding: Get notified immidiatlly once MedGenome has new funding data
Product Launch: Get notified when MedGenome launches new products
MedGenome, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if MedGenome has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined MedGenome as Masked Content
Find more new buyers
Compare Similar Companies to MedGenome
Compare insights from companies similar to MedGenome, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MedGenome is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MedGenome is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MedGenome.
MedGenome Tech Stack
A closer look at the technologies used by MedGenome
See more technologies
Most Recent Scoops
Person-Based
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Person-Based
Acquisitions, Corporate Strategy
Person-Based
Person-Based
MedGenome News & Media
Dr Rupesh Dagar, Chief Commercial Officer, Medgenome - Medical Buyer
Medical Buyer has long set a benchmark in healthcare journalism with its insightful coverage and deep industry analysis. Its dedication to informing and connecting the healthcare community has been instrumental in fostering awareness and collaboration across the sector. By highlighting emerging technologies, innovations, and success stories, the magazine enables decision-makers to make informed choices. Through […]MedGenome Raises USD 47.5 Mn in Series E Funding Round - Outlook Business
Genomic diagnostics and research services company MedGenome on Monday said it has raised USD 47.5 million in Series E funding round from private equity firm Maj Invest and existing investor Novo HoldingsSignios Bio Launches with AI-Driven Bioinformatics and Advanced Multiomics Platform to Power the Future of Precision Medicine and Drug Discovery
FOSTER CITY, Calif.--(BUSINESS WIRE)--Signios Biosciences ("Signios Bio"), a science-first biotechnology company at the forefront of multiomics and AI-powered bioinformatics, today announced its rebranding from its previous identity as the US based research division of MedGenome Inc. This milestone marks a new era, better positioning the brand in the US on its mission of long-term partnership with researchers to accelerate precision medicine and drug discovery. A New Brand with a Bold Vision WiMedGenome Appoints Industry Veterans Felix Olale, M.D., Ph.D., as CEO and Jennifer Rose as Chief Commercial Officer to Lead U.S. Expansion
FOSTER CITY, Calif.--(BUSINESS WIRE)--MedGenome appoints industry veterans Dr. Felix Olale and Jennifer Rose to lead U.S. expansion.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MedGenome
Sign Up For FreeTo access detailed company insights
MedGenome (www.medgenome.com) is a global leader in personalized medicine with 3 core businesses spanning genomic diagnostics, genomic research, and genomic medicine. MedGenome has a world class high-throughput Next-Generation Sequencing facility and bioinformatics team in Foster City, California, supporting biomarker identification, target discove... Read More
